A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
Status:
Completed
Trial end date:
2013-08-28
Target enrollment:
Participant gender:
Summary
The study will assess the safety and efficacy of QGE031 in the treatment of moderate to
severe atopic dermatitis patients. In addition, QGE031 levels in the blood will be measured
and the effect of QGE031 on markers in the blood and skin will be evaluated. Comparisons of
the effect of QGE31 will be made with placebo and also cyclosporine, a treatment already
established as being effective in atopic dermatitis.